Related Experiment Video
Updated: Jun 3, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
SLC35A2 gene product modulates paramyxovirus fusion events during infection
Yanling Yang1,2, Yuchen Wang1,2, Danielle E Campbell3
1Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Abstract:
Paramyxoviruses are significant human and animal pathogens that include mumps virus (MuV), Newcastle disease virus (NDV) and the murine parainfluenza virus Sendai (SeV). Despite their importance, few host factors implicated in paramyxovirus infection are known. Using a recombinant SeV expressing destabilized eGFP (rSeVCdseGFP) in a loss-of-function CRISPR screen, we identified the CMP-sialic acid transporter (CST) gene SLC35A1 and the UDP-galactose transporter (UGT) gene SLC35A2 as essential for paramyxovirus infection. As expected, SLC35A1 knockout (KO) cells showed drastic reduction in infections with SeV, NDV and MuV due to the lack of cell surface sialic acids receptors. However, SLC35A2 KO cells revealed unknown critical roles for this factor in virus-cell and cell-to-cell fusion events for the different paramyxoviruses. While UGT was essential for virus-cell fusion during SeV entry to the cell, it was not required for NDV or MuV entry. Importantly, UGT promoted the formation of syncytia during MuV infection, suggesting a role in cell-to-cell virus spread. Our findings demonstrate that paramyxoviruses can bind to or enter A549 cells in the absence of canonical galactose-bound sialic-acid decorations and show that UGT facilitates paramyxovirus fusion processes involved in entry and spread.
Insights
Researchers discovered that the UDP-galactose transporter (UGT) is crucial for paramyxovirus fusion, impacting viral entry and spread. This finding reveals new host factors essential for paramyxovirus (MuV, NDV, SeV) infection beyond sialic acid receptors.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Paramyxoviruses, including mumps virus (MuV), Newcastle disease virus (NDV), and Sendai virus (SeV), are significant human and animal pathogens.
- Knowledge of host factors governing paramyxovirus infection remains limited.
Purpose of the Study:
- To identify novel host factors essential for paramyxovirus infection using a loss-of-function CRISPR screen.
- To elucidate the specific roles of identified host factors in paramyxovirus entry and cell-to-cell spread.
Main Methods:
- A recombinant Sendai virus (SeV) expressing destabilized enhanced green fluorescent protein (rSeVCdseGFP) was used in a loss-of-function CRISPR screen.
- Knockout (KO) cell lines for SLC35A1 (CMP-sialic acid transporter - CST) and SLC35A2 (UDP-galactose transporter - UGT) were generated and infected with SeV, NDV, and MuV.
- Virus-cell and cell-to-cell fusion events were analyzed in KO cells.
Main Results:
- SLC35A1 KO cells exhibited significantly reduced infection by SeV, NDV, and MuV, consistent with the absence of sialic acid receptors.
- SLC35A2 KO cells demonstrated critical roles for UGT in virus-cell and cell-to-cell fusion for various paramyxoviruses.
- UGT was essential for SeV entry but not for NDV or MuV entry, yet it promoted syncytia formation in MuV infections, indicating a role in cell-to-cell spread.
- Paramyxoviruses can infect cells lacking canonical sialic acid decorations, and UGT facilitates fusion processes for paramyxovirus entry and spread.
Conclusions:
- The UDP-galactose transporter (UGT) plays a critical, previously unrecognized role in paramyxovirus fusion.
- UGT's function in fusion is virus-specific, affecting entry and/or cell-to-cell spread.
- These findings expand our understanding of host-pathogen interactions in paramyxovirus infections, identifying UGT as a key facilitator of fusion events.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019